Hunniwell Lake Ventures

Hunniwell Lake Ventures is a Palo Alto-based venture capital firm founded in 2019, specializing in the healthcare sector, with a particular focus on medical devices. The firm targets early-stage companies that innovate in areas such as surgical robotics, electrosurgical technologies, and disease detection systems. Their investment strategy emphasizes reducing technology and regulatory risks by backing innovations that build upon proven technologies. The firm also leverages a global network of suppliers, distributors, and hospital partnerships to help startups scale rapidly and achieve market penetration. Hunniwell typically invests in startups with existing sales teams and distribution channels, aiming to accelerate their growth through strategic partnerships, especially in China, and by sharing infrastructure and expertise. Their portfolio includes notable companies like WaveClear Vascular and CoapTech. Key figures at Hunniwell include Richard Fang and Daniel Teo, both managing partners with extensive backgrounds in medical technology investments. They are supported by industry veterans like John Ashley, an Entrepreneur-in-Residence, who has a track record of leading multiple successful exits in the medtech space.